Published in J Neuroimmunol on November 05, 1990
Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc Natl Acad Sci U S A (1994) 2.82
Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis. J Exp Med (1995) 2.62
Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells. J Exp Med (2009) 2.13
Antibody facilitation of multiple sclerosis-like lesions in a nonhuman primate. J Clin Invest (1995) 1.54
Oral tolerance. Proc Natl Acad Sci U S A (1994) 1.35
Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones. J Clin Invest (1993) 1.27
Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation. J Clin Invest (1995) 1.24
Diversity and plasticity of self recognition during the development of multiple sclerosis. J Clin Invest (1997) 1.07
Oligodendrocyte-specific expression and autoantigenicity of transaldolase in multiple sclerosis. J Exp Med (1994) 1.05
Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein. J Clin Invest (1996) 0.98
Multiantigen/multiepitope-directed immune-specific suppression of "complex autoimmune encephalomyelitis" by a novel protein product of a synthetic gene. J Clin Invest (2002) 0.86
Progression of relapsing-remitting demyelinating disease does not require increased TCR affinity or epitope spread. J Immunol (2014) 0.84
Cleavage of transaldolase by granzyme B causes the loss of enzymatic activity with retention of antigenicity for multiple sclerosis patients. J Immunol (2010) 0.82
Comparative analysis of antibody and cell-mediated autoimmunity to transaldolase and myelin basic protein in patients with multiple sclerosis. J Clin Invest (1997) 0.81
Mapping autoantigen epitopes: molecular insights into autoantibody-associated disorders of the nervous system. J Neuroinflammation (2016) 0.76
Immunological aspects of demyelinating diseases. Annu Rev Immunol (1992) 4.39
Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature (1990) 3.50
Adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice after in vitro activation of lymph node cells by myelin basic protein: requirement for Lyt 1+ 2- T lymphocytes. J Immunol (1981) 3.15
Prevention and treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 1. J Immunol (1991) 2.80
Detection of cell-dependent cytotoxic antibody to cells infected with herpes simplex virus. Nature (1974) 2.55
Ataxia-telangiectasia. Medicine (Baltimore) (1972) 2.50
Isolation of an HTLV-1-like retrovirus from patients with tropical spastic paraparesis. Nature (1988) 2.27
Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals. J Immunol (1990) 2.07
Further studies on the specificity of presumed immune associations of myasthenia gravis and consideration of possible pathogenic implications. Ann N Y Acad Sci (1966) 2.02
Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: implications for clinical trials and natural history. Ann Neurol (1991) 2.00
Adoptive transfer of myelin basic protein-sensitized T cells produces chronic relapsing demyelinating disease in mice. Nature (1984) 1.95
Skewed T-cell receptor repertoire in genetically identical twins correlates with multiple sclerosis. Nature (1993) 1.89
Relapsing experimental allergic encephalomyelitis in the SJL/J mouse. Lab Invest (1981) 1.84
A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis. J Exp Med (1991) 1.84
Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course. J Immunol (1995) 1.76
Multiple sclerosis (first of two parts). N Engl J Med (1982) 1.72
Experimental allergic encephalomyelitis: enhancement of cell-mediated transfer by concanavalin A. J Immunol (1977) 1.58
Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis. Ann Neurol (1993) 1.58
Acute experimental allergic encephalomyelitis in the mouse: immunopathology of the developing lesion. Cell Immunol (1985) 1.52
Impaired lymphocyte transformation in ataxia-telangiectasia in part due to a plasma inhibitory factor. J Immunol (1969) 1.51
Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis. Ann Neurol (1992) 1.50
Evidence of endogenous regulatory function of transforming growth factor-beta 1 in experimental allergic encephalomyelitis. Int Immunol (1992) 1.43
Immunoglobulin A production in ataxia telangiectasia. Science (1965) 1.41
Diversity in fine specificity and T cell receptor usage of the human CD4+ cytotoxic T cell response specific for the immunodominant myelin basic protein peptide 87-106. J Immunol (1992) 1.40
An unusual form of diabetes mellitus in ataxia telangiectasia. N Engl J Med (1970) 1.38
Immunoglobulin metabolism in ataxia telangiectasia. J Clin Invest (1968) 1.38
Induction of experimental allergic encephalomyelitis in PL/J and (SJL/J x PL/J)F1 mice by myelin basic protein and its peptides: localization of a second encephalitogenic determinant. J Immunol (1983) 1.35
The germline repertoire of T cell receptor beta-chain genes in patients with chronic progressive multiple sclerosis. J Neuroimmunol (1989) 1.32
Induction of subacute murine measles encephalitis by monoclonal antibody to virus haemagglutinin. Nature (1981) 1.30
Contact sensitivity in the pig. Immunology (1973) 1.30
Immunological studies in tropical spastic paraparesis. Ann Neurol (1990) 1.26
Recurrent experimental allergic encephalomyelitis in the Lewis rat. J Immunol (1974) 1.26
Cell type-specific regulation of major histocompatibility complex (MHC) class I gene expression in astrocytes, oligodendrocytes, and neurons. Glia (1993) 1.25
Neuropathology of experimental allergic encephalomyelitis in inbred strains of mice. Lab Invest (1980) 1.24
Experimental allergic encephalomyelitis in the rat: response to encephalitogenic proteins and peptides. Science (1973) 1.21
Clinical worsening in multiple sclerosis is associated with increased frequency and area of gadopentetate dimeglumine-enhancing magnetic resonance imaging lesions. Ann Neurol (1993) 1.20
Relapsing murine experimental allergic encephalomyelitis induced by myelin basic protein. J Immunol (1983) 1.20
Lymph node function and lymphocyte circulation in the pig. Adv Exp Med Biol (1973) 1.20
Thymic epithelial cell contains acetylcholine receptor. Lancet (1977) 1.18
Multiple sclerosis (second of two parts). N Engl J Med (1982) 1.18
Adoptively transferred chronic relapsing experimental autoimmune encephalomyelitis in the mouse. Neuropathologic analysis. Lab Invest (1984) 1.17
Regulation of MHC class I and beta 2-microglobulin gene expression in human neuronal cells. Factor binding to conserved cis-acting regulatory sequences correlates with expression of the genes. J Immunol (1993) 1.15
Immune response of Lewis rats to peptide C1 (residues 68-88) of guinea pig and rat myelin basic proteins. J Exp Med (1977) 1.15
Immunological findings in neurological diseases associated with antibodies to HTLV-I: activated lymphocytes in tropical spastic paraparesis. Ann Neurol (1988) 1.14
Adoptive transfer of murine chronic-relapsing autoimmune encephalomyelitis. Analysis of basic protein-reactive cells in lymphoid organs and nervous system of donor and recipient animals. J Neuroimmunol (1987) 1.13
Presentation of myelin basic protein by murine cerebral vascular endothelial cells. J Immunol (1985) 1.11
Chronologic neuropathology of relapsing experimental allergic encephalomyelitis in the mouse. Lab Invest (1982) 1.11
Scrapie in immunologically deficient mice. Nature (1971) 1.10
Immunologic responses of progressive multiple sclerosis patients treated with an anti-T-cell monoclonal antibody, anti-T12. Neurology (1986) 1.09
The immune response against myelin basic protein in two strains of rat with different genetic capacity to develop experimental allergic encephalomyelitis. J Exp Med (1975) 1.09
Human cellular immune response to measles virus polypeptides. J Virol (1984) 1.07
Purification of measles virus with preservation of infectivity and antigenicity. J Gen Virol (1979) 1.06
Cellular immune response to measles, mumps, and vaccinia viruses in multiple sclerosis. Ann Neurol (1979) 1.06
Astrocytes: auxiliary cells for immune responses in the central nervous system? Immunol Today (1990) 1.05
Encephalitogenic activity of guinea pig myelin basic protein in the SJL mouse. J Immunol (1982) 1.05
Transthyretin Pro55, a variant associated with early-onset, aggressive, diffuse amyloidosis with cardiac and neurologic involvement. Hum Genet (1992) 1.05
Cell-mediated immunity to myelin-associated glycoprotein, proteolipid protein, and myelin basic protein in multiple sclerosis. J Neuroimmunol (1986) 1.04
Immune reactivity of the purified hemagglutinin of measles virus. Infect Immun (1981) 1.04
Does myasthenic serum bind to the neuromuscular junction? Ann N Y Acad Sci (1966) 1.03
Isolation of HTLV-II from a patient with chronic, progressive neurological disease clinically indistinguishable from HTLV-I-associated myelopathy/tropical spastic paraparesis. Ann Neurol (1993) 1.02
Evaluation of the structural proteins of the hamster neurotropic strain of measles virus with monoclonal antibodies. J Neuroimmunol (1986) 1.01
Systemic histiocytosis presenting as multiple sclerosis. Ann Neurol (1993) 1.01
Monospecific antibody to the haemagglutinin of measles virus. J Gen Virol (1980) 1.00
The response of human lymphocyte subpopulations to measles, mumps, and vaccinia viral antigens. J Immunol (1980) 0.99
A preliminary trial of poly(I,C)-LC in multiple sclerosis. J Biol Response Mod (1985) 0.99
HTLV-I-specific cytotoxic T lymphocytes in the cerebrospinal fluid of patients with HTLV-I-associated neurological disease. Ann Neurol (1992) 0.99
Biosynthesis of measles virus hemagglutinin in persistently infected cells. Arch Virol (1983) 0.99
Immunopathology of the lesion in chronic relapsing experimental autoimmune encephalomyelitis in the mouse. Cell Immunol (1986) 0.98
Quantitation of IgG, IgA and IgM in the CSF by radioimmunoassay. Neurology (1978) 0.98
Antibodies to the structural polypeptides of measles virus following acute infection and in SSPE. Clin Exp Immunol (1980) 0.98
Altered blood T-cell subsets in patients with multiple sclerosis. J Neuroimmunol (1984) 0.97
Interaction between myelin basic protein-sensitized T lymphocytes and murine cerebral vascular endothelial cells. J Immunol (1986) 0.96
Demyelinating disease after neurologically complicated primary Epstein-Barr virus infection. Neurology (1992) 0.94
Cytokine-regulated adhesion between encephalitogenic T lymphocytes and cerebrovascular endothelial cells. J Neuroimmunol (1993) 0.94
Measles virus-polypeptide specificity of the cytotoxic T-lymphocyte response in multiple sclerosis. J Neuroimmunol (1989) 0.92
Long-term treatment of chronic relapsing experimental allergic encephalomyelitis by transforming growth factor-beta 2. J Neuroimmunol (1993) 0.92
Central-nervous-system lesions detected by magnetic resonance imaging in an HTLV-1 antibody positive symptomless individual. Lancet (1987) 0.92
The use of cyclophosphamide in the treatment of multiple sclerosis. Ann N Y Acad Sci (1984) 0.92
Experimental allergic encephalomyelitis induced by the peptide encoded by exon 2 of the MBP gene, a peptide implicated in remyelination. J Neuroimmunol (1994) 0.92
Muscle lesions in myasthenia gravis. Discussion. Ann N Y Acad Sci (1966) 0.91
Encephalitogenic epitopes of myelin basic protein. Chem Immunol (1989) 0.91
Idiotypes and biological activity of murine monoclonal antibodies against the hemagglutinin of measles virus. Infect Immun (1981) 0.90
Oligoclonal bands in CSF: twins with MS. Neurology (1984) 0.90
Use of interferon in multiple sclerosis. Ann Neurol (1985) 0.90
Cloned measles virus-specific T lymphocytes from a twin with multiple sclerosis. Proc Natl Acad Sci U S A (1983) 0.90
Chronic relapsing experimental allergic encephalomyelitis. Cytotoxicity effected by a class II restricted T cell line specific for an encephalitogenic epitope. J Immunol (1989) 0.89
Lectin receptors in central nervous system myelin. J Neurochem (1980) 0.89
Immunology of multiple sclerosis. Ann Allergy (1990) 0.89
Humoral and cellular immune responses to matrix protein of measles virus in subacute sclerosing panencephalitis. J Virol (1988) 0.89
Lymphoid depletion and immunosuppression after thymectomy in the young pig. Nat New Biol (1972) 0.88
Myelin basic protein-specific T-cell responses in identical twins discordant or concordant for multiple sclerosis. Ann Neurol (1993) 0.88
Cerebral vascular endothelial cells are effective targets for in vitro lysis by encephalitogenic T lymphocytes. J Immunol (1991) 0.87
Superantigen modulation of experimental allergic encephalomyelitis: activation of anergy determines outcome. J Immunol (1994) 0.86
Molecular analysis of HTLV-I proviral integration and T cell receptor arrangement indicates that T cells in tropical spastic paraparesis are polyclonal. J Infect Dis (1989) 0.86
Peripheral polyneuropathy, high and low molecular weight IgM, and amyloidosis. Arch Neurol (1971) 0.86
Monoclonal antibody specific for myelin glycoprotein P0: derivation and characterization. Proc Natl Acad Sci U S A (1982) 0.85
Adoptively transferred acute and chronic relapsing autoimmune encephalomyelitis in the PL/J mouse and observations on altered pathology by intercurrent virus infection. Lab Invest (1987) 0.85
Changes in the amount of diseased white matter over time in patients with relapsing-remitting multiple sclerosis. Neurology (1995) 0.85
The immune response against an encephalitogenic fragment of guinea pig basic protein in the Lewis and Brown Norway strains or rat. J Immunol (1975) 0.84
Measles-specific T cell clones derived from a twin with multiple sclerosis: genetic restriction studies. J Immunol (1985) 0.84